Distinct molecular mechanisms of acquired resistance to temozolomide in glioblastoma cells (original) (raw)

MGMTGene Silencing and Benefit from Temozolomide in Glioblastoma

The New England Journal of Medicine, 2005

Genetic alterations associated with acquired temozolomide resistance in SNB-19, a human glioma cell line

Molecular Cancer Therapeutics, 2006

Tumor mutational burden and purity adjustment before and after treatment with temozolomide in 27 paired samples of glioblastoma: a prospective study

Jannick Brennum

Molecular Oncology, 2021

View PDFchevron_right

Protracted Adjuvant Temozolomide in Glioblastoma Multiforme

Dina Salem

Journal of Cancer Therapy, 2015

View PDFchevron_right

The SIAH1–HIPK2–p53ser46 Damage Response Pathway is Involved in Temozolomide-Induced Glioblastoma Cell Death

Bernd Kaina

Molecular Cancer Research, 2019

View PDFchevron_right

Identification of a transient state during the acquisition of temozolomide resistance in glioblastoma

Lisa Oliver

Cell Death & Disease

View PDFchevron_right

Temozolomide resistance in glioblastoma occurs by miRNA-9-targeted PTCH1, independent of sonic hedgehog level

Jessian Munoz

Oncotarget, 2015

View PDFchevron_right

Multifaceted Resistance of Gliomas to Temozolomide1

Demetrius Kokkinakis

2002

View PDFchevron_right

Extended-schedule dose-dense temozolomide in refractory gliomas

Miguel Angel Garcia Gil

Journal of Neuro-Oncology, 2009

View PDFchevron_right

On the Critical Issues in Temozolomide Research in Glioblastoma: Clinically Relevant Concentrations and MGMT-independent Resistance

Aleksei A Stepanenko

Biomedicines

View PDFchevron_right

Evaluation of novel imidazotetrazine analogues designed to overcome temozolomide resistance and glioblastoma regrowth

Jarkko Rautio

Molecular Cancer Therapeutics, 2014

View PDFchevron_right

Multifaceted resistance of gliomas to temozolomide

Demetrius Kokkinakis

Clinical cancer …, 2002

View PDFchevron_right

Inhibition of prolyl 4-hydroxylase, beta polypeptide (P4HB) attenuates temozolomide resistance in malignant glioma via the endoplasmic reticulum stress response (ERSR) pathways

Cf Fung

Neuro-Oncology, 2013

View PDFchevron_right

Glioblastoma vs temozolomide: can the red queen race be won?

Anjali Arora

Cancer Biology & Therapy, 2019

View PDFchevron_right

Temozolamide-Associated Pancytopenia in a Patient with Glioblastoma Multiforme

Kübra BOZKURT

International Journal of Case Reports, 2019

View PDFchevron_right

Ewa Obuchowicz

Research Square (Research Square), 2023

View PDFchevron_right

In search of effective therapies to overcome resistance to Temozolomide in brain tumours

Cancer Drug Resistance

Cancer Drug Resistance, 2019

View PDFchevron_right

Tumor response of temozolomide in combination with morphine in a xenograft model of human glioblastoma

Giacomo Signorino

Oncotarget, 2017

View PDFchevron_right

Acquisition of temozolomide resistance by the rat C6 glioma cell line increases cell migration and side population phenotype

Jiejing Li

Oncology Reports

View PDFchevron_right

Dianhydrogalactitol Overcomes Multiple Temozolomide Resistance Mechanisms in Glioblastoma

Alberto J. Schuhmacher

Molecular Cancer Therapeutics, 2021

View PDFchevron_right

Temozolomide resistance and tumor recurrence: Halting the Hedgehog

Jessian Munoz

Cancer cell & microenvironment

View PDFchevron_right

Temozolomide resistance in glioblastoma cells occurs partly through epidermal growth factor receptor-mediated induction of connexin 43

Pranela Rameshwar

Cell death & disease, 2014

View PDFchevron_right

Inhibitors of GLUT/SLC2A Enhance the Action of BCNU and Temozolomide against High-Grade Gliomas

Francesca Garello

Neoplasia, 2017

View PDFchevron_right

Temozolomide Resistance in Glioblastoma by NRF2: Protecting the Evil

Marcela Latancia

Biomedicines

View PDFchevron_right

Mismatch Repair Deficiency Does Not Mediate Clinical Resistance to Temozolomide in Malignant Glioma

Francis Ali-Osman

Clinical Cancer Research, 2008

View PDFchevron_right

Inhibition of DNA repair for sensitizing resistant glioma cells to temozolomide

Isabelle Germano

Journal of Neurosurgery, 2003

View PDFchevron_right

Temozolomide in malignant gliomas: current use and future targets

Linda Bressler

Cancer Chemotherapy and Pharmacology, 2009

View PDFchevron_right

Distinct molecular mechanisms of acquired resistance to temozolomide in glioblastoma cells (original) (raw)

Related papers